Trans-Tasman biotech collaborations sought
03 June, 2002 by Pete YoungNew Zealand's political leadership is declaring the Land of the Long White Cloud open for collaborative ventures with Australia's biotech sector.
Peptech upbeat despite half year loss
31 May, 2002 by David BinningAustralian biotechnology company Peptech posted a net loss of $4.6 million on Wednesday for the half-year ended March 31, 2002, but said that the progress of key patents in the US would guarantee meaningful new revenue streams going forward.
Biotechs need to focus on early-stage R&D: experts
31 May, 2002 by Tanya HollisAustralia's biotech sector needed to focus on improving early stage compound validation to reduce the exorbitant costs of project attrition, experts said yesterday.
No plans to slow down for Austin's retiring director
30 May, 2002 by Tanya HollisWhen Nobel medicine laureate Dr George Snell accepted his 1980 award for identifying genetically determined cell surface immune response regulators, six peers received his thanks. One was an Australian - Prof Ian McKenzie.
Meditech snares Moses for board
30 May, 2002 by Tanya HollisDrug delivery company Meditech Research has named sought-after business analyst Bob Moses as chairman of its board.
New study of testosterone deficiency
29 May, 2002 by Tanya HollisA collaboration between men's health specialists and pathologists aims to create a precision reference kit to diagnose testosterone deficiency in men.
Monsanto, Aventis to bid for GM canola production
29 May, 2002 by Melissa TrudingerMonsanto has confirmed that it is getting ready to file its submission for commercial production of its GM Roundup Ready canola variety to the Office of the Gene Technology Regulator (OGTR).
States flex their muscles over GM-free zones
29 May, 2002 by Pete YoungThe rights of the states to designate agricultural zones in which genetically modified crops can be either banned or permitted has been reinforced by the body overseeing the national regulatory framework for gene technology.
Bionomics broadens Genmab collaboration
29 May, 2002 by Tanya HollisBionomics has added a third target to its antibody development collaboration with Danish biotech Genmab, broadening the project's product potential.
Norwood gains US patent
28 May, 2002 by Tanya HollisTransdermal drug delivery company Norwood Abbey has gained US patent approval of a laser technology for internal drug delivery.
Cellestis teams up to test TB
28 May, 2002 by Tanya HollisDiagnostics developer Cellestis has entered a collaboration to test and distribute a tuberculosis diagnostic designed specifically for the Japanese market.
New members for Anadis' advisory panel
28 May, 2002 by Tanya HollisOne local and one international scientist have joined the ranks of natural biopharmaceutical developer Anadis.
WA feature: Silicon valley in the west
28 May, 2002 by Pete YoungPerth biotech pSiVida has reversed the normal flow of events by bringing in offshore technology and funding its further development out of West Australia.
Portland Orthopaedics expands
27 May, 2002 by Daniella GoldbergMedical device company Portland Orthopaedics has expanded into a larger Sydney-based facility to develop and manufacture its new style of hip and knee replacement joints.
CRC students digging ethical minefields
27 May, 2002 by Daniella GoldbergLast week's Cooperative Research Centre Association conference revealed that ethical issues and public consultation are pertinent to the technological developments currently undertaken by Australian CRCs.
